Study of gene therapy developed at St. Jude Children’s Research Hospital and University College London offers first proof that the treatment benefits adults with hemophilia B; reduces need for clotting factor to prevent bleeds.
Read More...
[Source: St. Jude Children's Research Hospital - Latest News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment